The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
about
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studiesIdentification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiationBindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infectionRANK-RANKL signalling in cancerOsteoprotegerin rich tumor microenvironment: implications in breast cancerPresent Advances and Future Perspectives of Molecular Targeted Therapy for OsteosarcomaBone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisAnti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidencesStructure-based development of a receptor activator of nuclear factor- B ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosisCytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-AnalysisOsteoblasts Are the Centerpiece of the Metastatic Bone MicroenvironmentKey roles of the OPG-RANK-RANKL system in bone oncologyBoon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with AngiogenesisTargeting bone remodeling by isoflavone and 3,3'-diindolylmethane in the context of prostate cancer bone metastasisWhy don't we get more cancer? A proposed role of the microenvironment in restraining cancer progressionDifferential expression and tumor necrosis factor-mediated regulation of TNFRSF11b/osteoprotegerin production by human melanomas.Adjunctive antimicrobial photodynamic treatment of experimentally induced periodontitis in rats with ovariectomy.Rutile and titanium particles differentially affect the production of osteoblastic local factors.Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.Effects of neuropeptides and mechanical loading on bone cell resorption in vitro.Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro.Areca nut extract protects against ovariectomy-induced osteoporosis in mice.Trabecular bone volume and osteoprotegerin expression in uremic rats given high calcium.Alpha-calcitonin gene-related peptide can reverse the catabolic influence of UHMWPE particles on RANKL expression in primary human osteoblasts.A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures.Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles.Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsEffect of orthodontic forces on cytokine and receptor levels in gingival crevicular fluid: a systematic review.Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.Bone Healing in Ovariectomized-rabbit Calvarial Defect with Tricalcium Phosphate Coated with Recombinant Human Bone Morphogenetic Protein-2 Genetically Engineered in Escherichia coliPlasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages.Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in IGF-I deficient mice.Osteoporosis in chronic obstructive pulmonary diseaseGhrelin Increases Beta-Catenin Level through Protein Kinase A Activation and Regulates OPG Expression in Rat Primary Osteoblasts.Constitutive expression of cathepsin K in the human intervertebral disc: new insight into disc extracellular matrix remodeling via cathepsin K and receptor activator of nuclear factor-κB ligand.
P2860
Q24289320-36FD3ED0-C519-4359-B230-2F22E75F68EBQ24657159-37694FD8-001C-435F-8514-F0238C329F5EQ24701763-E87E826D-5A86-4DC1-8D93-3B4EBCA815D3Q26747442-A4B3CDE6-1AB8-48AF-8080-CDD247473D8DQ26748804-82234981-A79E-48C7-985D-23F5A6E56445Q26750631-3D85AED4-4F74-4FFD-937A-4FC7857F65F9Q26771376-D2A5AB0E-80EB-4E90-93FB-443261DD3D92Q26773017-5D9AE573-4720-428C-9512-2E238C375ED2Q26863493-B781A7FB-F44E-4BF2-9526-C0CA1CCB4C6EQ27665673-E2EE2D7F-0F97-4DAB-BCA4-C8315DA9D491Q28067502-8C0FEBD8-DAF5-43B6-A870-BCE28EFB747EQ28077461-7DD39D2F-E8BE-474D-88B8-56EC4CFEC0B1Q28287394-3E8D057E-00F4-40D4-97CA-AE788FAC6401Q28611365-5AB548B1-3C22-4FC8-9EAF-563DB5E6FF22Q28731449-3A83D5DD-8417-4F20-A622-047831C13FADQ29614274-BC20B1C0-1D21-4ABC-8CA1-2A5E40CB3E7CQ30412235-6142B8B1-C9C8-4D7C-806A-DDFD4607CB4FQ31063890-6D5F3F23-1666-4C2E-AD1C-1F9B86D45B73Q33289750-CE5EB966-0883-41D1-A2CD-31FD7D97046CQ33307072-45A836A5-BA90-49C1-8194-5AD147FFD999Q33580516-C890DA87-8E4F-46E8-8FC1-34363D55C0B3Q33716948-BBA200D8-5F9E-45D5-B4BC-A91590B7AAD4Q33744420-41B7594B-67D5-4E8A-839D-8437454900DFQ34118018-69754C86-6EE3-45B8-B6FD-E311EC91D4C3Q34156735-39ADE8D4-4E0A-4C2A-8239-CE559EC89DE8Q34171853-3F31BF74-D395-442F-A01C-B341A76D2967Q34332098-5B98015B-C707-46F7-9AE0-CED083901CAFQ34503355-4B485905-E62B-48A3-BCE1-B747B9DB022AQ34547523-C80EB36E-DC35-4AE8-A088-D8EE6693A3C5Q34555532-CD75D6F8-F3CB-40CD-947F-B9487B450838Q34657931-15C846EB-5475-435B-8147-DC24DFE540D5Q34664057-2CEB0962-76D9-4243-A04E-644658049020Q34802870-5E22A15E-70E2-4074-8A26-35A2AE61B418Q34828137-44362F94-F89A-4D72-97DD-5B95B665A2ACQ34950497-6A705FE8-C77B-4C21-96CD-F85E0675FB85Q34993353-8458E50B-B7CA-4327-BC80-B6D30DD083C1Q35087758-7915236B-7ABA-4125-B148-8EB2E33D5CD0Q35173349-0E3D2455-9B1F-4DB9-AA21-33D8C0E296FAQ35238712-8C903044-586C-4F82-B0A3-470D093006E0Q35617758-EC4CCB7F-D51C-425F-B8E5-9198E2B2FD44
P2860
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@ast
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@en
type
label
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@ast
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@en
prefLabel
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@ast
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@en
P2093
P1476
The molecular triad OPG/RANK/R ...... physiological bone remodeling.
@en
P2093
Francoise Redini
Sandrine Theoleyre
Steeve Kwan Tat
Yannick Fortun
Yohann Wittrant
P304
P356
10.1016/J.CYTOGFR.2004.06.004
P577
2004-12-01T00:00:00Z